Filing Flows › Abbott Laboratories (ABT) › Guidance history
Abbott Laboratories (ABT) guidance history: what it guided and what it reported
Abbott Laboratories gave guidance in 12 earnings releases on file since Jan 24, 2024. Its releases raised guidance 4 times and lowered it once.
GAAP EPS
This line is not in the statements Filing Flows reads, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| Q4 2024 | $0.96–$1.02 (Oct 16, 2024) | — | — | — |
| Q3 2024 | $0.85–$0.89 (Jul 18, 2024) | — | — | — |
| Q2 2024 | $0.69–$0.73 (Apr 17, 2024) | — | — | — |
| FY2024 | $3.20–$3.40 (Jan 24, 2024) → raised $3.25–$3.40 (Apr 17, 2024) → raised $3.30–$3.40 (Jul 18, 2024) → raised $3.34–$3.40 (Oct 16, 2024) | — | — | — |
Adjusted EPS
The guide is on an adjusted basis that the GAAP statements do not show, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| Q4 2026 | $1.62–$1.67 (Oct 21, 2026) | — | to be reported | — |
| Q3 2026 | $1.38–$1.46 (Jul 16, 2026) | — | — | — |
| Q2 2026 | $1.25–$1.31 (Apr 16, 2026) | — | — | — |
| Q1 2026 | $1.12–$1.18 (Jan 22, 2026) | — | — | — |
| FY2026 | $5.55–$5.80 (Jan 22, 2026) → lowered $5.38–$5.58 (Apr 16, 2026) → raised $5.45–$5.60 (Jul 16, 2026) → reaffirmed $5.50–$5.55 (Oct 21, 2026) | — | to be reported | — |
| Q3 2025 | $1.28–$1.32 (Jul 17, 2025) | — | — | — |
| Q2 2025 | $1.23–$1.27 (Apr 16, 2025) | — | — | — |
| Q1 2025 | $1.05–$1.09 (Jan 22, 2025) | — | — | — |
| FY2025 | $5.05–$5.25 (Jan 22, 2025) → reaffirmed $5.05–$5.25 (Apr 16, 2025) → reaffirmed $5.10–$5.20 (Jul 17, 2025) → reaffirmed $5.12–$5.18 (Oct 15, 2025) | — | — | — |
| Q4 2024 | $1.31–$1.37 (Oct 16, 2024) | — | — | — |
The latest quarter
Abbott Laboratories, Q3 2026: revenue $13.0B (+14% year over year), operating margin 10.4%, net earnings $920M, operating cash flow $1.7B. The chart follows the revenue to costs, profit and cash.
Questions
Does Abbott Laboratories beat its guidance?
Abbott Laboratories gave guidance in 12 earnings releases on file since Jan 24, 2024. Its releases raised guidance 4 times and lowered it once.
How often does Abbott Laboratories raise guidance?
Its earnings releases raised guidance 4 times and lowered it once since Jan 24, 2024.
Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.